Highly fluorinated amphiphiles as drug and gene carrier and delivery systems
暂无分享,去创建一个
[1] D. Lasič. Sterically Stabilized Vesicles , 1994 .
[2] J. Riess,et al. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. , 1998, Biochimie.
[3] R. Doms,et al. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide , 1994, Journal of virology.
[4] P. Vierling,et al. Synthesis and evaluation of the in vivo tolerance of amido fiuorocarbon/fluorocarbon and fluorocarbon/hydrocarbon double-chain phosphocholines deriving from diaminopropanols and serine , 1995 .
[5] J. Riess,et al. Phagocytic uptake by mouse peritoneal macrophages of microspheres coated with phosphocholine or polyethylene glycol phosphate-derived perfluoroalkylated surfactants , 1995 .
[6] T. McIntosh,et al. Structure and interactive properties of highly fluorinated phospholipid bilayers. , 1996, Biophysical journal.
[7] J. Lasch. Interaction of detergents with lipid vesicles. , 1995, Biochimica et biophysica acta.
[8] P. Vierling,et al. New Perfluoroalkylated Phospholipids as Injectable Surfactants: Synthesis, Preliminary Physicochemical, and Biocompatibility Data. , 1992 .
[9] G. Gregoriadis,et al. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. , 1982, Life sciences.
[10] J. Devoisselle,et al. NEW (PERFLUOROALKYL)ALKYL DIMETHYLAMMONIUM BROMIDE-BASED VESICLES EXHIBITING TRAPPING AND RELEASE PROPERTIES. STUDY OF THEIR TOXICITY IN CONTACT WITH SKIN , 1997 .
[11] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Sirlin,et al. Gene transfer with a series of lipophilic DNA-binding molecules. , 1994, Bioconjugate chemistry.
[13] P. Vierling,et al. Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. , 1994, Biochimica et biophysica acta.
[14] P. Vierling,et al. Polymorphic phase behavior of fluorocarbon double-chain phosphocholines derived from diaminopropanol, serine and ethanolamine and long-term shelf stability of their liposomes , 1997 .
[15] Andrew D. Miller. Cationic Liposomes for Gene Therapy , 1998 .
[16] P. Mukerjee,et al. Adsorption of fluorocarbon and hydrocarbon surfactants to air-water, hexane-water and perfluorohexane-water interfaces. Relative affinities and fluorocarbon-hydrocarbon nonideality effects , 1981 .
[17] H. Hofland,et al. Formulation and Delivery of Nucleic Acids , 1999 .
[18] P. Vierling,et al. Membrane permeability and stability of liposomes made from highly fluorinated double-chain phosphocholines derived from diaminopropanol, serine or ethanolamine. , 1997, Biochimica et biophysica acta.
[19] P. Vierling,et al. MISCIBILITY OF BINARY MIXTURES OF HIGHLY FLUORINATED DOUBLE-CHAIN GLYCEROPHOSPHOCHOLINES AND 1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE (DPPC) , 1997 .
[20] P. Vierling,et al. Phase behavior of fluorocarbon and hydrocarbon double-chain hydroxylated and galactosylated amphiphiles and bolaamphiphiles. Long-term shelf-stability of their liposomes. , 1999, Chemistry and physics of lipids.
[21] A M Aubertin,et al. Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity. , 2000, Carbohydrate research.
[22] P. Vierling,et al. Highly Stable Liposomes Derived from Perfluoroalkylated Glycerophosphocholines , 1991 .
[23] P. Vierling,et al. Polymorphic phase behavior of perfluoroalkylated phosphatidylcholines. , 1994, Biochimica et biophysica acta.
[24] U. Persson,et al. Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma. , 1999, Acta oncologica.
[25] P. Vierling,et al. Fluorinated phosphatidylcholine-based liposomes: H+/Na+ permeability, active doxorubicin encapsulation and stability, in human serum. , 1994, Biochimica et biophysica acta.
[26] Chi‐Huey Wong. Mimics of Complex Carbohydrates Recognized by Receptors , 1999 .
[27] P. Vierling,et al. Phase behavior of fluorocarbon di-O-alkyl-glycerophosphocholines and glycerophosphoethanolamines and long-term shelf stability of fluorinated liposomes. , 1997, Biochimica et biophysica acta.
[28] J. Fantini,et al. Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3) , 1999, Journal of Virology.
[29] J. V. Von Roenn,et al. Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[30] J. Fantini,et al. Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29 , 1997, AIDS.
[31] J. Fantini,et al. Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3* , 1998, The Journal of Biological Chemistry.
[32] P. Vierling,et al. Transmembrane pH-driven Na+ permeability of fluorinated phospholipid-based membranes. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[33] Abdallah,et al. Gene transfer with lipospermines and polyethylenimines. , 1998, Advanced drug delivery reviews.
[34] J. Greiner,et al. Carbohydrate- and related polyol-derived fluorosurfactants: an update. , 2000, Carbohydrate research.
[35] K. Ikeda,et al. Synthesis of N-acetylglucosaminyl- and N-acetylgalactosaminylceramides as cerebroside analogs and their anti-human immunodeficiency virus type 1 activities. , 1997, Chemical & pharmaceutical bulletin.
[36] P. Vierling,et al. Synthesis of Highly Fluorinated Di-O-alk(en)yl-glycerophospholipids and Evaluation of Their Biological Tolerance , 1996 .
[37] J. Fantini,et al. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. , 1998, Biochemical and biophysical research communications.
[38] P. Vierling,et al. Membrane permeability and stability in buffer and in human serum of fluorinated di-O-alkylglycerophosphocholine-based liposomes. , 1996, Biochimica et biophysica acta.
[39] Chi-Huey Wong,et al. Carbohydrate Mimetics: A New Strategy for Tackling the Problem of Carbohydrate‐Mediated Biological Recognition , 1999 .
[40] P. Vierling,et al. synthesis of single- and double-chain fluorocarbon and hydrocarbon β-linked galactose amphiphiles derived from serine , 1995 .
[41] P. Vierling,et al. Extended in vivo blood circulation time of fluorinated liposomes , 1993, FEBS letters.
[42] P. Vierling,et al. Molecular order and mobility within membranes made from fluorocarbon/fluorocarbon and fluorocarbon/hydrocarbon double-chain ether and amide phospholipids , 1997 .
[43] P. Vierling,et al. Improved stability of highly fluorinated phospholipid-based vesicles in the presence of bile salts. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[44] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[45] R. Rowland,et al. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. , 1980, Biochimica et biophysica acta.